
Dentsply Sirona Appoints Aldo M. Denti As Chief Commercial Officer And Announces Customer-Centric Organization
Mr. Denti is a global business leader with over 25 years of experience driving transformative growth in the Medical Device and Consumer Health sectors. His expertise spans sales, marketing, strategic planning, and successful integration across diverse markets. Mr. Denti has a proven track record of delivering revenue growth and operational efficiency. Most recently, he served as Company Group Chairman, Global Orthopedics, at Johnson & Johnson Medtech.
“I am pleased to welcome Aldo as our new CCO and rejoin forces with him,” said Daniel Scavilla, President and Chief Executive Officer of Dentsply Sirona.“Aldo is a results-oriented innovator with exceptional leadership in navigating dynamic, fast-paced environments and engaging stakeholders worldwide. His expertise will strengthen collaboration across business units and regions, unlock synergies, and support global revenue growth by leveraging our unique portfolio of products and solutions. Aldo will lead our global sales strategy and execution to deliver superior growth, profitability, and customer satisfaction across all regions. Additionally, by bringing our Global Business Units and Commercial Organizations even closer together, the new CCO role will drive a strong focus on the customer and the customer experience. Our new structure will simplify how we work and allow for faster execution.”
Mr. Denti said,“I am honored to join Dentsply Sirona at such an exciting time for the Company. Together with the team, I look forward to advancing our operational goals while strengthening our commercial execution. I strongly believe in the potential of Dentsply Sirona as the world's largest diversified manufacturer in the dental industry and we will execute on key strategic growth drivers across regions.”
About Aldo M. Denti
Mr. Denti was most recently Company Group Chairman, Global Orthopedics, at Johnson & Johnson Medtech, a main segment of Johnson & Johnson, one of the world's largest healthcare companies. Prior to his current role, Mr. Denti served as Vice President Global Franchise of Johnson & Johnson Vision. Earlier in his career, Mr. Denti held various leadership roles in EMEA for the Johnson & Johnson orthopedics business and other sales and marketing roles outside Johnson & Johnson. He began his professional path with Pfizer, progressing through sales and marketing leadership roles in Switzerland, the UK and the US. He later worked for Medtronic and Wright Medical in Europe and the US. Mr. Denti speaks six languages and holds a bachelor's degree with honors from York University in Toronto, Canada, and completed Executive Education Programs at Harvard Business School.
About Dentsply Sirona
Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona's innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona's headquarters is located in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
...
Press:
Marion Par-Weixlberger
Vice President, Public Relations, Corporate Communications & Brand
...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- New Cryptocurrency Mutuum Finance (MUTM) Raises $15.8M As Phase 6 Reaches 40%
- Noveba Brings Apple Pay To Customers
- Mutuum Finance (MUTM) Approaches Next Phase With 14.3% Price Increase After Raising $16 Million
- Cregis And Kucoin Host Institutional Web3 Forum Discussing Industry Trends And Opportunities
- Primexbt Expands Crypto Futures With 101 New Coins, Delivering Best-In-Class Trading Conditions
- BTCC Exchange Announces Triple Global Workforce Expansion At TOKEN2049 Singapore To Power Web3 Evolution
Comments
No comment